Trypanosoma cruzi DNA (T. cruzi DNA)

Trypanosoma cruzi DNA is the genetic material of the protozoan parasite responsible for Chagas disease, a major cause of heart failure and gastrointestinal complications in the Americas. The genome is uniquely organized into nuclear DNA and a dense mitochondrial DNA network called the kinetoplast (kDNA), which consists of thousands of interlocked minicircles and maxicircles. This DNA is a primary target for the current frontline treatments, benznidazole and nifurtimox, which are prodrugs activated by parasite-specific nitroreductases. The resulting reactive metabolites cause extensive DNA damage, including alkylation and oxidative lesions, which inhibit replication and trigger parasite death. Beyond its role as a drug target, the presence of T. cruzi DNA in the blood is the definitive biomarker used in polymerase chain reaction (PCR) assays to diagnose infection and evaluate treatment success.

Other names

Kinetoplast DNAkDNATrypanosoma cruzi genomeNuclear DNA of Trypanosoma cruzi

The primary mechanism involves the enzymatic reduction of nitroheterocyclic prodrugs by parasite-specific nitroreductases, generating reactive intermediates that cause DNA alkylation, oxidative damage, and double-strand breaks. Additionally, certain compounds may bind to the minor groove of kinetoplast DNA or interfere with DNA topoisomerases, leading to the collapse of the kDNA network and inhibition of parasite replication.